ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1574 • 2015 ACR/ARHP Annual Meeting

    Associations of Serum Anti-Malondialdehyde-Acetaldehyde (MAA) Antibodies with Cardiovascular and Respiratory Mortality in Men with Rheumatoid Arthritis

    Bryant R. England1, Geoffrey M. Thiele2, Michael J. Duryee3, Lynell Klassen4, Jeremy Sokolove5, William H. Robinson6, Daniel Anderson7, Harlan Sayles7, Kaleb Michaud8, Liron Caplan9, Lisa A. Davis9, Grant W. Cannon10, Brian Sauer11, E. Blair Solow12, Andreas Reimold13, Gail S. Kerr14, Pascale Schwab15, Joshua F. Baker16 and Ted R. Mikuls17, 1Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 2Research Services 151, Omaha VA Medical Center, Omaha, NE, 3Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 4Dept of Internal Medicine, Univ of Nebraska Med Ctr, Omaha, NE, 5Division of Immunology and Rheumatology, Stanford University Medical Center, Mountain View, CA, 6Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 7University of Nebraska Medical Center, Omaha, NE, 8Rheumatology & Immunology, University of Nebraska Medical Center and National Data Base for Rheumatic Diseases, Omaha, NE, 9Div of Rheumatology, Univ of CO Denver School of Med, Aurora, CO, 10Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 11Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 12Rheumatology, UT Southwestern Medical Center, Dallas, TX, 13Rheumatology, VAMC, University of Texas Southwestern Medical Center, Dallas, TX, 14VAMC, Georgetown University, Washington, DC, 15Div Arth & Rheum Dis, Oregon Health & Sci Univ OP09, Portland, OR, 16Rheumatology, University of Pennsylvania, Philadelphia, PA, 17Medicine, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Mortality from cardiovascular (CV) and respiratory causes is increased in rheumatoid arthritis (RA). Predictive serologic biomarkers of these events are lacking. Previously, we have…
  • Abstract Number: 1575 • 2015 ACR/ARHP Annual Meeting

    Serum Vascular Cell Adhesion Molecule-1 (VCAM-1) Levels Are Associated with Vascular Dysfunction and Increased Cardiovascular Risk in an Animal Model and Patients with Rheumatoid Arthritis

    Ruth Davies1, Daniela Iacono2, Lauren A. Jordan1, Jessica O Williams1, Charlotte Rawlings1, Derek Lang3, Anwen S. Williams1 and Ernest H. Choy1, 1Cardiff University, Institute of Infection and Immunity, Tenovus Building, University Hospital of Wales, Cardiff, United Kingdom, 2Department of Clinical and Experimental Medicine. Rheumatology Section. Second University of Naples, Naples, Italy, 3Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom

    Background/Purpose:  Mortality is increased in Rheumatoid arthritis (RA) patients mainly due to cardiovascular (CV) disease; however the biologic mechanisms are unknown. Increased CV risk in…
  • Abstract Number: 1576 • 2015 ACR/ARHP Annual Meeting

    Effect of Conventional Synthetic and Biological Disease Modifying Anti-Rheumatic Drugs on the Immunogenicity of Hepatitis B Vaccine in Patients with Rheumatoid Arthritis

    Samanan Intongkam1, Rattapol Pakchotanon2, Sumapa Chaiamnuay2, Paijit Asavatanabodee2 and Pongthorn Narongroeknawin2, 1Internal medicine, Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand, 2Rheumatic Disease Unit, Department of Internal Medicine, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand

    Background/Purpose: Immunogenicity of pneumococcal and influenza vaccine in patients with rheumatoid arthritis (RA) have been assessed in many studies. However, the humoral immune response of…
  • Abstract Number: 1577 • 2015 ACR/ARHP Annual Meeting

    Periodontal Evaluation Is Associated with Increased Likelihood of Achieving Low Disease Activity in Rheumatoid Arthritis with Methotrexate

    Melanie Rohr1, James R. O'Dell1, Abhijeet Danve2, Harlan Sayles1, Geoffrey M. Thiele3, Jeffrey Payne4 and Ted R. Mikuls5, 1University of Nebraska Medical Center, Omaha, NE, 2Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3Research Services 151, Omaha VA Medical Center, Omaha, NE, 4College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, 5Medicine, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA) outcomes have improved substantially due to the development of new drug therapies, but also due to emphasis on early aggressive MTX…
  • Abstract Number: 1578 • 2015 ACR/ARHP Annual Meeting

    Serum Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Are Associated with Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis: A Population-Based Study

    Elana J. Bernstein1, R. Graham Barr2, John H.M. Austin3, Steven M. Kawut4, Ganesh Raghu5, Jessica L. Sell6, Eric A. Hoffman7, John D. Newell Jr.8, Jubal R. Watts Jr.9, P. Hrudaya Nath10, Sushil K. Sonavane9, Joan M. Bathon1, Darcy S. Majka11 and David J. Lederer2, 1Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 2Medicine, Columbia University College of Physicians & Surgeons, New York, NY, 3Radiology, Columbia University College of Physicians & Surgeons, New York, NY, 4Division of Pulmonary, Allergy, and Critical Care, University of Pennsylvania, Philadelphia, PA, 5University of Washington, Seattle, WA, 6Columbia University College of Physicians & Surgeons, New York, NY, 7University of Iowa, Iowa City, IA, 8Radiology, University of Iowa, Iowa City, IA, 9Radiology, University of Alabama at Birmingham, Birmingham, AL, 10University of Alabama at Birmingham, Birmingham, AL, 11Division of Rheumatology, Northwestern University, Chicago, IL

    Background/Purpose: Approximately 30% of adults diagnosed with interstitial lung disease (ILD) have an underlying established autoimmune disease. Based on the strong links between autoimmunity and…
  • Abstract Number: 1579 • 2015 ACR/ARHP Annual Meeting

    Association of Myocardial Abnormalities with N-Terminal Pro-Brain Natriuretic Peptide and Disease Activity in Rheumatoid Arthritis without Cardiac Symptoms, Assessed By Cardiac Magnetic Resonance Imaging

    Hitomi Kobayashi1, Yasuyuki Kobayashi2, Isamu Yokoe3, Natsumi Ikumi4,5, Hirotake Inomata6, Atsuma Nishiwaki6, Noboru Kitamura1, Kaita Sugiyama6, Hidetake Shiraiwa6, Masataka Nozaki6, Yosuke Nagasawa6, Yoshihiro Matsukawa5 and Masami Takei1, 1Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 2Advanced Biomedical Imaging Informatics, St.Marianna University School of Medicine, Kawasaki, Japan, 3Rheumatology, Itabashi Chuo Medical Center, Tokyo, Japan, 4Nihon University School of Medicine, Shinjuku, Japan, 5Division of Heamatology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 6Nihon University School of Medicine, Tokyo, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is a multi-organ inflammatory disorder associated with high cardiovascular morbidity and mortality. Cardiac involvements are typically clinically silent, only manifesting as…
  • Abstract Number: 1580 • 2015 ACR/ARHP Annual Meeting

    Abnormal High Density Lipoproteins in Synovial Fluid from Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Arthritis

    Christina Charles-Schoeman1, Yuen Yin Lee2, Ani Shahbazian1, David Meriwether3, Peter Kim2 and Srinivasa T. Reddy4, 1Medicine-Rheumatology, University of California Los Angeles, Los Angeles, CA, 2Medicine- Rheumatology, University of California Los Angeles, Los Angeles, CA, 3Medicine- Cardiology, University of California Los Angeles, Los Angeles, CA, 4Medicine-Cardiology, University of California Los Angeles, Los Angeles, CA

    Background/Purpose:   High levels of rheumatoid arthritis (RA) disease activity have been associated with abnormal function of circulating high density lipoproteins (HDL) and increased cardiovascular…
  • Abstract Number: 1581 • 2015 ACR/ARHP Annual Meeting

    Cardiac Involvement in Patients with Amyloid a Amyloidosis Due to Rheumatoid Arthritis

    Daisuke Kobayashi1, Satoshi Ito1, Yoko Wada2, Akira Murasawa1, Ichiei Narita2 and Kiyoshi Nakazono1, 1Niigata Rheumatic Center, Shibata, Japan, 2Department of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is one of the major causes of amyloid A (AA) amyloidosis, the major organs affected being the kidneys and gastrointestinal (GI)…
  • Abstract Number: 1582 • 2015 ACR/ARHP Annual Meeting

    Joint Damage Associated with Loss of Body Mass in Rheumatoid Arthritis

    Jose Felix Restrepo1, Inmaculada del Rincon2, Daniel Battafarano3 and Agustin Escalante4, 1Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, 3Rheumatology, San Antonio Military Medical Center, JBSA - Ft Sam Houston, TX, 4Dept. of Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX

    Background/Purpose: Body mass index (BMI) is a predictor of long-term outcome in rheumatoid arthritis and has been associated with joint damage. Our objective was to examine…
  • Abstract Number: 1583 • 2015 ACR/ARHP Annual Meeting

    Identifying Risk Factors for Progression of Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Yashaar Chaichian1, Dina Bassiri2, Imre Noth3, Mary Strek3, Tammy Utset1 and Rekha Vij3, 1Medicine, Section of Rheumatology, University of Chicago Medical Center, Chicago, IL, 2Statistical & Applied Research, ACT, Inc., Iowa City, IA, 3Medicine, Section of Pulmonary/Critical Care, University of Chicago Medical Center, Chicago, IL

    Background/Purpose: Interstitial lung disease (ILD) is recognized as a frequent extra-articular manifestation of rheumatoid arthritis (RA) associated with significant morbidity and mortality. Nevertheless, risk factors…
  • Abstract Number: 1584 • 2015 ACR/ARHP Annual Meeting

    Metabolic Syndrome Is Associated with Disease Activity in Patients with Rheumatoid Arthritis: A Prospective Cohort Study

    Pongchirat Tantayakom1, Ajchara Koolvisoot1, Emvalee Arromdee1, Praveena Chiowchanwisawakit1, Chayawee Muangchan1 and Wanruchada Katchamart2, 1Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Medicine, Division of Rheumatology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease involving articular and extra-articular systems, including cardiovascular (CVS), respiratory, as well as hematologic systems, etc.…
  • Abstract Number: 1585 • 2015 ACR/ARHP Annual Meeting

    Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Disease-Modifying Anti-Rheumatic Drug Therapy: A Retrospective Cohort Study Using UK Primary Care Electronic Medical Records

    Ruth Costello1, Kevin L. Winthrop2, Stephen R Pye1 and William G Dixon3, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 2Oregon Health and Science University, Portland, OR, 3Manchester Academic Health Sciences Centre, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: The guidelines for the management of rheumatoid arthritis (RA) recommend an annual influenza vaccine and a pneumonia vaccination (EULAR, 2011), prior to starting disease-modifying…
  • Abstract Number: 1586 • 2015 ACR/ARHP Annual Meeting

    Weight Loss in Obese Rheumatoid Arthritis (RA) Patients Improves Disease Activity without Modifying RA Treatment

    Elisa Gremese1, Maria Rita Gigante1, Barbara Tolusso1, Anna Laura Fedele1, Silvia Canestri1, Barbara Aquilanti2, Clara Di Mario1, Luca Petricca1, Stefano Alivernini1 and Gianfranco Ferraccioli1, 1Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 2Dietology Service, Association Columbus, Catholic University of the Sacred Heart, Rome, Italy

    Background/Purpose: Obesity is recognized as a systemic, low-grade inflammatory state and the adipose tissue as an endocrine organ releasing pro-inflammatory cytokines. On the other hand,…
  • Abstract Number: 1587 • 2015 ACR/ARHP Annual Meeting

    Deriving a Comorbidity Index Form the Meddra Classification: Performance of  Rheumatic Disease Comorbidity Index, Charlson-Deyo Index and Functional Comorbidity Index Among Patients with RA in NOR-DMARD Cohort

    Polina Putrik1, Sofia Ramiro2, Elisabeth Lie3, Andras Keszei4, Tore K. Kvien5, Till Uhlig6 and Annelies Boonen7, 1Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Epidemiology, Maastricht University, Maastricht, Netherlands, 5Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 6Diakonhjemmet Hospital, Oslo, Norway, 7Maastricht University Medical Center, Maastricht, Netherlands

    Background/Purpose: Comorbidities have an important impact on outcomes in chronic diseases. A new and simple to compute index, the Rheumatic Disease Comorbidity Index (RDCI), has…
  • Abstract Number: 1588 • 2015 ACR/ARHP Annual Meeting

    Increased Fracture Risk in Patients with Early Rheumatoid Arthritis: A Prospective General Population-Matched Cohort Study

    Britt-Marie Nyhäll-Wåhlin1, Sofia Ajeganova2, Ingemar F Petersson3 and Maria LE Andersson4, 1Department of Rheumatology, Falun Hospital, Falun, Sweden, 2Rheumatology unit, Department of Medicine,, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden, 3Lund University, Department of Orthopedics, Clinical Sciences Lund, Lund, Sweden, 4R&D Centre Spenshult, Halmstad, Halmstad, Sweden

    Background/Purpose: Fragility fractures represent one of the serious extra-articular manifestations of rheumatoid arthritis (RA). The aim of this study was to investigate whether fracture incidence…
  • « Previous Page
  • 1
  • …
  • 1792
  • 1793
  • 1794
  • 1795
  • 1796
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology